Generic diabetes combo pill put to the test in healthy volunteers
NCT ID NCT07633054
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested whether a new tablet containing empagliflozin and metformin works the same in the body as the reference drug Synjardy. Forty-two healthy adults took a single dose of each version under fed conditions. The goal was to check bioequivalence, meaning the two drugs release the same amount of active ingredient at the same rate.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Empagliflozin/Metformin
What this could lead to
If the test tablet is shown to be equivalent, it could offer a more affordable or accessible option for managing type 2 diabetes.
What could go wrong
This was a small, early-stage study in healthy people, not patients. Results may not predict real-world effectiveness or safety in those with diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALENCE STUDY IN HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Axis Clinicals Latina, S.A. de C.V.
Mexico City, Mexico City, 07870, Mexico